 |
|
Acute hepatitis C virus infection: clinical update and remaining challenges
Chen-Hua Liu, Jia-Horng Kao
Clin Mol Hepatol. 2023;29(3):623-642. Published online 2023 Feb 20 DOI: https://doi.org/10.3350/cmh.2022.0349
|
|
Citations to this article as recorded by
 Safety considerations in the management of hepatitis C and HIV co-infection
Vicente Soriano, Víctor Moreno-Torres, Ana Treviño, Pablo Barreiro, Fernando de Jesus, Octavio Corral, Carmen de Mendoza
Expert Opinion on Drug Safety.2023; 22(5): 363. CrossRef Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials
Palak K. Parikh, Nisha H. Parikh, Mahalakshmi B, Ketan M. Ranch, Sai H.S. Boddu, Jayachandra Babu R, Amit K. Tiwari
Arabian Journal of Chemistry.2023; 16(8): 105013. CrossRef Oryza sativa L. Indica Seed Coat Ameliorated Concanavalin A—Induced Acute Hepatitis in Mice via MDM2/p53 and PKCα/MAPK1 Signaling Pathways
Zhiye Zhao, Ye Li, Shancheng Guo, Yuxu Chen, Haiaolong Yin, Yaxian Li, Guiguang Cheng, Lei Tian
International Journal of Molecular Sciences.2023; 24(19): 14503. CrossRef Planning a Clinical Trial Programme for Direct-Acting Antivirals for Chronic Viral Hepatitis C
A. I. Gubenko, D. V. Goryachev, A. I. Muravieva, G. V. Shukshina
Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation.2023;[Epub] CrossRef A Synopsis of Hepatitis C Virus Treatments and Future Perspectives
Christian Medina, Alexis Hipólito García, Francis Isamarg Crespo, Félix Isidro Toro, Soriuska José Mayora, Juan Bautista De Sanctis
Current Issues in Molecular Biology.2023; 45(10): 8255. CrossRef
|